These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 556662)

  • 1. Thrombotic thrombocytopenic purpura with C'3 vascular deposits: report of a case.
    Weisenburger DD; O'Conner ML; Hart MN
    Am J Clin Pathol; 1977 Jan; 67(1):61-3. PubMed ID: 556662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative immunopathologic studies of thrombotic thrombocytopenic purpura, hemolytic-uremic syndrome and disseminated intravascular coagulation.
    Hayasaka T; Yoshiki T; Shirai T; Ninomura N; Itoh T
    Acta Pathol Jpn; 1981 Jul; 31(4):569-81. PubMed ID: 7197110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thrombotic thrombocytopenic purpura with IgM deposition in small arterial walls of the spleen].
    Arashi M; Akahonai Y; Ikebe M; Hinoda Y; Ohshima T; Abe T; Yachi A; Dempo K
    Rinsho Ketsueki; 1983 Jul; 24(7):868-73. PubMed ID: 6685197
    [No Abstract]   [Full Text] [Related]  

  • 4. Thrombotic thrombocytopenic purpura: report of a case with possible immune etiology.
    Mant MJ; Cauchi MN; Medley G
    Blood; 1972 Sep; 40(3):416-21. PubMed ID: 4626870
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunological studies of thrombotic thrombocytopenic purpura].
    Koyama T; Kakishita E
    Nihon Rinsho; 1993 Jan; 51(1):155-8. PubMed ID: 8433510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated platelet-surface-bound IgM in thrombotic thrombocytopenic purpura.
    Bodensteiner D; Rosenfeld C
    South Med J; 1988 Jan; 81(1):81-3. PubMed ID: 3336804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AJKD Atlas of Renal Pathology: Thrombotic Microangiopathy.
    Lusco MA; Fogo AB; Najafian B; Alpers CE
    Am J Kidney Dis; 2016 Dec; 68(6):e33-e34. PubMed ID: 27884283
    [No Abstract]   [Full Text] [Related]  

  • 8. Complement activation in thrombotic microangiopathy.
    Karpman D; Tati R
    Hamostaseologie; 2013 May; 33(2):96-104. PubMed ID: 23411690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombotic thrombocytopenic purpura. Report of a case presenting as a chronic neurological disorder and characterized by unusual histological findings.
    BORNSTEIN B; BOSS JH; CASPER J; BEHAR M
    J Clin Pathol; 1960 Mar; 13(2):124-32. PubMed ID: 13802905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathology of renal diseases associated with dysfunction of the alternative pathway of complement: C3 glomerulopathy and atypical hemolytic uremic syndrome (aHUS).
    Sethi S; Fervenza FC
    Semin Thromb Hemost; 2014 Jun; 40(4):416-21. PubMed ID: 24799306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo metabolism of complement. I. Metabolism of the third component (C'3) in acquired hemolytic anemia.
    Petz LD; Fink DJ; Letsky EA; Fudenberg HH; Müller-Eberhard J
    J Clin Invest; 1969 Nov; 47(11):2469-84. PubMed ID: 4975569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic and other factors in thrombotic thrombocytopenic purpura (TTP).
    Neame PB
    Semin Thromb Hemost; 1980; 6(4):416-29. PubMed ID: 7013072
    [No Abstract]   [Full Text] [Related]  

  • 13. Human neutrophil peptides and complement factor Bb in pathogenesis of acquired thrombotic thrombocytopenic purpura.
    Cao W; Pham HP; Williams LA; McDaniel J; Siniard RC; Lorenz RG; Marques MB; Zheng XL
    Haematologica; 2016 Nov; 101(11):1319-1326. PubMed ID: 27662014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement in thrombotic thrombocytopenic purpura.
    Garvey MB; Freedman J
    Am J Hematol; 1983 Dec; 15(4):397-8. PubMed ID: 6685975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultralarge von Willebrand factor-induced platelet clumping and activation of the alternative complement pathway in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndromes.
    Turner N; Sartain S; Moake J
    Hematol Oncol Clin North Am; 2015 Jun; 29(3):509-24. PubMed ID: 26043389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thrombotic thrombocytopenic purpura. An immune-complexes disease? (author's transl)].
    Celada A; Laso FJ; Perrin LH
    Sangre (Barc); 1979; 24(5):593-9. PubMed ID: 161419
    [No Abstract]   [Full Text] [Related]  

  • 17. Breakdown products of C 3 in human synovial fluids.
    Zvaifler NJ
    J Clin Invest; 1969 Aug; 48(8):1532-42. PubMed ID: 4183680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated platelet-associated IgG in thrombotic thrombocytopenic purpura.
    Morrison J; McMillan R
    JAMA; 1977 Oct; 238(18):1944-5. PubMed ID: 578556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C'3 participation in the rejection of some experimental tumors.
    Bellelli L; Sezzi ML
    Oncology; 1976; 33(5-6):215-8. PubMed ID: 1026854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter: Plasma-C3 in haemolytic-uraemic syndrome and thrombotic thrombocytopenic purpura.
    Cameron JS; Vick R
    Lancet; 1973 Oct; 2(7835):975. PubMed ID: 4795545
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.